FDA Inspection 737190 — SpecGx LLC

SpecGx LLC — FEI 1021320

The FDA completed an inspection of SpecGx LLC on July 21, 2011 in Raleigh, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 21, 2011
Fiscal Year
2011
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Raleigh, NC (United States)